Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Last trade$15.88
Day change+$0.51 (+3.32%)
Day range$14.60 – $16.25
Volume204,428
Market cap$291M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for SCTX.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for SCTX, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Revenue
$1.64M
Cost of revenue
$0
Gross profit
$1.64M
Selling, general and administrative
$4.24M
Research and development
$8.26M
Total operating expenses
$12.5M
Operating income
-$10.86M
Interest expense
$0
Income before taxes
-$9.63M
Income taxes
$231K
Net income
-$9.86M
Net income attributable to common shareholders
-$9.86M
EBITDA
-$10.24M
Basic earnings per share
-$0.68
Diluted earnings per share
-$0.68
Recent news
Company coverage with links to the original publishers.
Cathie Wood's Ark Invest made selective purchases on Monday, adding to positions in Nvidia, SoFi Technologies, and Scribe Therapeutics despite a generally bullish market day. Nvidia faced headwinds from a spy scandal investigation involving CEO Jensen Huang but remains attractively valued. SoFi showed strong fundamentals with 35% member growth and 44% revenue increase, though it's down 41% over the past year. Scribe Therapeutics, a gene-editing biotech, has sufficient cash runway through early 2029.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.